Published in AIDS Weekly, October 13th, 2003
The VDR measures the decline in viral load concentration after the start of therapy. Additionally, virologic failure after 48 weeks in patients treated with the drugs was shown to be unrelated to a higher VDR. The results of the sub-study were presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
"The results of this 2NN sub-study offer further evidence of the comparable virologic efficacy of Viramune and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.